Haleon plc has agreed to purchase approximately £230 million worth of ordinary shares from Pfizer, related to Pfizer’s proposed offering on September 30, 2024, as part of their share buyback program.
AI Assistant
HALEON PLC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.